Core Viewpoint - iPower Inc. is strategically expanding into crypto infrastructure hardware through a non-binding MOU with Nanopulse Technology Ltd, aiming to leverage its supply chain and e-commerce capabilities to commercialize hardware at scale, potentially generating recurring income from future hardware sales [1][2][3] Group 1: Strategic Expansion - The initiative is designed to address the operational challenges faced by blockchain networks that require physical hardware deployment but lack the capacity for sales and support in the U.S. [2] - iPower aims to act as an execution and distribution layer for crypto-native projects, establishing a repeatable model for future infrastructure partnerships within the crypto ecosystem [1][3] Group 2: Economic Model - The MOU includes discussions on multi-layered economics, which may involve immediate revenue from hardware sales and ongoing commission-based income from future hardware distributed through iPower [3] - iPower emphasizes that this initiative is focused on hardware distribution and infrastructure enablement, not on providing financial services or engaging in digital asset trading [5] Group 3: Future Participation - The parties plan to explore iPower's potential role as a U.S.-based validator or node operator, which would be subject to separate agreements [4] - This exploratory participation would be governed by standalone agreements, indicating a cautious approach to expanding into new areas of the crypto market [4] Group 4: Company Overview - iPower Inc. operates at the intersection of digital assets and real-world commerce, providing supply chain and infrastructure services for online retailers and brands [6] - The company is executing a broader crypto strategy through licensed partners and compliant infrastructure, highlighting its commitment to integrating crypto solutions into its business model [6]

Core Insights - LiveOne has launched its award-winning app on VIZIO smart TVs, providing users with free 24/7 access to its music service [1][2] - The app enhances LiveOne's distribution, reaching over 1.3 billion monthly active users across various platforms [4] Company Overview - LiveOne is a creator-first music, entertainment, and technology platform headquartered in Los Angeles, CA, focusing on delivering premium experiences through memberships and live events [2] - The company operates several subsidiaries, including Slacker, PodcastOne, and LiveXLive, and offers its services across multiple devices and platforms [2] Product Features - The LiveOne app allows users to listen to hundreds of curated music stations across more than 30 genres and create custom stations based on their preferences [5] - Users receive personalized recommendations for music and podcasts, access popular podcast shows, and can watch live streaming performances and interviews [5] - The app also offers curated video content and subscription tiers that provide additional features such as ad-free listening and offline playback [5] Strategic Partnerships - LiveOne anticipates forming at least two additional Fortune 250 B2B partnerships by the end of the year, further expanding its market reach [4]

Core Viewpoint - INmune Bio Inc. is advancing its clinical development of XPro1595 for early Alzheimer's disease, with a webinar scheduled to discuss the registrational pathway and recent trial results [1][2]. Group 1: Clinical Development - The Phase 2 MINDFuL trial has been completed, and feedback from the FDA supports moving to a registrational study for Alzheimer's patients with inflammation biomarkers [2]. - XPro1595 is a next-generation selective soluble TNF inhibitor aimed at restoring immune homeostasis in the brain without affecting transmembrane TNF or TNF receptors [3][10]. Group 2: Webinar Details - The webinar will cover three main topics: results from the MINDFuL trial, the design of the registrational study, and the strategic roadmap to Phase 3, including global partnership opportunities [3][4][5]. - Featured speakers include Dr. Michael Woodward and Dr. Sharon Cohen, both recognized experts in Alzheimer's disease research [6]. Group 3: Company Overview - INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments targeting the innate immune system, with three product platforms: CORDStrom™, XPro™, and INKmune® [11].

Core Viewpoint - Fortress Biotech, Inc. and its subsidiary Cyprium Therapeutics announced the sale of a Rare Pediatric Disease Priority Review Voucher for $205 million, highlighting the company's strategic focus on value-generating transactions and advancements in their product pipeline [1][3]. Company Developments - Cyprium Therapeutics has transferred the development and commercialization rights of ZYCUBO to Sentynl Therapeutics, which was approved by the FDA on January 12, 2026, for treating Menkes disease [2]. - The PRV was issued following the FDA approval of ZYCUBO, and Cyprium is set to receive tiered royalties on net sales and up to $129 million in development and sales milestones from Sentynl [2]. - Cyprium is obligated to pay 20% of the PRV sale proceeds to the Eunice Kennedy Shriver National Institute of Child Health and Human Development [2]. Strategic Positioning - Fortress Biotech's Chairman emphasized the significance of the PRV sale and recent FDA approvals for their products, indicating a strong position to execute on their portfolio [3]. - Cyprium's recent achievements include the approval of ZYCUBO and the execution of the asset sale, with plans to advance AAV-ATP7A Gene Therapy for Menkes disease [3]. Company Background - Cyprium Therapeutics focuses on developing therapies for Menkes disease and related disorders, having established a partnership with the Eunice Kennedy Shriver National Institute of Child Health and Human Development for clinical development [4]. - Fortress Biotech is an innovative biopharmaceutical company with a diverse portfolio, including eight marketed products and multiple development programs across various therapeutic areas [5].

Group 1 - Century Aluminum Company will have its President and CEO, Jesse Gary, present at the BMO Global Metals, Mining, & Critical Minerals Conference on February 24, 2026, at 8:15 a.m. EST [1] - A real-time audio webcast of the conference session will be accessible on the "Investors" section of Century's website [1] Group 2 - Century Aluminum Company is headquartered in Chicago, IL, and operates primary aluminum smelting facilities in the United States and Iceland [2] - The company is the majority owner and managing partner of the Jamalco alumina refinery located in Jamaica [2]

Core Insights - Algorhythm Holdings, Inc. has secured an additional $9.5 million under its existing $20 million financing facility, raising the total capital to $19.5 million, which positions the company to execute its global growth strategy for the SemiCab platform [1][2] Financial Position - Following the new funding, Algorhythm reported approximately $12.5 million in cash on hand, providing sufficient capital for the expansion of its SemiCab platform in India, the U.S., and other international markets [2] - The company has repaid approximately $7 million of the initial $10 million under the financing facility, enhancing its balance sheet and increasing stockholders' equity [3] Strategic Focus - The company aims to utilize the proceeds from the funding to accelerate U.S. go-to-market efforts for the newly launched SemiCab Apex SaaS platform, grow its customer base in India, expand into new freight logistics markets, and develop complementary products and services [6] Company Overview - Algorhythm Holdings, Inc. is a leading AI technology company focused on the growth of SemiCab, which addresses supply-chain challenges globally through its AI-enabled, cloud-based Collaborative Transportation Platform [4] - SemiCab's platform utilizes real-time data and advanced predictive optimization models to enhance logistics efficiency, allowing shippers to reduce costs while increasing carrier earnings [4]

Core Viewpoint - Tian Ruixiang Holdings Ltd is in advanced discussions for a strategic business combination with a leading InsurTech company in the Asia-Pacific region, alongside its ongoing Bitcoin acquisition strategy aimed at enhancing shareholder value [1][2][6]. Group 1: Strategic Business Combination - The InsurTech leader is characterized as a well-capitalized, high-growth entity with proprietary AI-driven underwriting, digital distribution, and automated claims processing [3]. - The proposed structure will position Tian Ruixiang as the exclusive public platform for the InsurTech to access U.S. capital markets, facilitating its global expansion [4]. - Existing shareholders of TIRX will maintain full public market ownership and benefit from the potential upside of the combined InsurTech platform [4][9]. Group 2: Shareholder Value Creation - The strategic initiatives are expected to attract significant institutional interest, expand analyst coverage, and create substantial shareholder value [5][9]. - The CEO emphasized that these initiatives represent a historic opportunity to unlock exceptional and sustainable value for shareholders, although no definitive agreement has been reached yet [6][7]. Group 3: Company Overview - Tian Ruixiang Holdings Ltd is a NASDAQ-listed holding company focused on insurance-related services in China, with a commitment to strategic transformation and maximizing long-term shareholder value [7].

Core Insights - SafeSpace Global Corporation has transitioned from a pre-revenue stage to generating recurring monthly revenue through the deployment of its AI-powered safety technology in eight senior living facilities as of February 2026 [1][3][10] Revenue Commencement and Contract Portfolio - The company has executed eight service contracts with senior living facility operators, marking a significant operational milestone and confirming the successful development and implementation of its product [3][4] - These contracts represent real revenue from actual deployments, with facilities now utilizing the technology in daily operations and compensating the company on a recurring monthly basis [4][11] Technology Overview - SafeSpace Global's platform utilizes proprietary AI technology to provide continuous, privacy-aware monitoring, enhancing resident safety without the need for intrusive wearables or alarm systems [5][6] - The system includes critical safety functions such as elopement detection, enhanced visitor management, and accelerated incident investigation and documentation [6][7] Addressing Industry Challenges - The technology addresses significant challenges in the senior living industry, including staffing shortages and regulatory scrutiny, by reducing manual monitoring demands and supporting consistent safety practices [8][9] - Facilities adopting this technology are positioned as leaders in resident safety and care quality, setting a new standard in the industry [12][13] Privacy and Compliance - The platform is designed to meet stringent privacy and security requirements, ensuring HIPAA compliance and incorporating various safeguards for protected health information [9] Growth Trajectory - The transition to active revenue generation is a critical inflection point for the company, with established contracts providing a foundation for future market penetration and revenue growth [10][11]

Core Viewpoint - Trust Stamp has partnered with IDetect to enhance ID scanning and entrance security solutions by integrating access to the AAMVA Driver's License Data Verification service, enabling real-time verification of driver's license data against official records [1][2][3] Company Overview - Trust Stamp is a global provider of AI-powered trust, identity, and security solutions, focusing on reducing fraud and enhancing operational efficiency across various sectors including banking, healthcare, and government [5][6] - IDetect, Inc. specializes in advanced ID scanning solutions, serving over 70 vertical markets such as hospitality, retail, and government, aimed at preventing identity fraud and ensuring regulatory compliance [7] Product Enhancement - The integration of AAMVA DLDV allows IDetect to move from simple document authentication to comprehensive data verification, significantly improving security measures against sophisticated forgeries [3][4] - This new capability is expected to process millions of verifications per month, setting a new standard in the ID scanning industry [4] Market Impact - The AAMVA DLDV integration will be available across IDetect's hardware and software solutions, providing a one-second verification process that enhances entrance security and reduces insurance liability [4]

PHILADELPHIA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI) (“Fermi” or the “Company”) on behalf of investors who purchased or otherwise acquired Fermi securities during the period of October 1, 2025 through December 11, 2025 (the “Class Period”), including in the Company’s initial public offering on October 1, 2025. Investor Deadline: Investors who purchased Fermi securities during th ...